NCT02656875View on ClinicalTrials.gov

A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

768

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

August 31, 2017

Conditions
Acute Pain
Interventions
DRUG

TRV130

Trial Locations (10)

10305

Staten Island

16801

Recruiting, State College

33155

Recruiting, Miami

36608

Recruiting, Mobile

39202

Recruiting, Jackson

71101

Recruiting, Shreveport

77004

Houston

77027

Houston

84123

Recruiting, Murray

91105

Recruiting, Pasadena

All Listed Sponsors
lead

Trevena Inc.

INDUSTRY

NCT02656875 - A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain | Biotech Hunter | Biotech Hunter